About
Knight Therapeutics Inc. (TO:GUD) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 15 2026
Knight to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference
Mar 27 2026
Knight Therapeutics Inc. ranks on The Globe and Mail's second annual Canada's Top Growing Women-Led Companies and seventh annual Women Lead Here benchmark of executive gender diversity
Mar 23 2026
Knight Amends Normal Course Issuer Bid
Mar 19 2026
Knight Therapeutics Reports Fourth Quarter and Year-End 2025 Results
Mar 17 2026
Knight Therapeutics Announces Approval of Additional Indication for MINJUVI® (tafasitamab) in Brazil
Financials
Revenue
CA$450.09 M
Market Cap
CA$739.7 M
EPS
-0.05